← All Sponsors
SPONSOR

Hanmi Pharmaceutical Company Limited

Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 2
Conditions studied: HypertensionObeseObesity
NCT06174766 Phase 3
Recruiting

A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients

Hypertension
South Korea View Trial →
NCT07205900 Phase 2
Recruiting

Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus

Obese
United States View Trial →